Immunservice is a biopharmaceutical company addressing orphan disease indications as well as large market indication areas, especially those of high unmet medical need. Immunservice's unique biomimetic approach translates human immune hormones into well tolerated and highly effective marketable drugs that improve survival and quality of life in patients. Biomimetic therapy has the clear potential to cure patients with cancer, even those who are in urgent need and have little or no treatment alternatives.
View Top Employees from ImmunserviceWebsite | http://www.immunservice.com |
Revenue | $8 million |
Employees | 3 (3 on RocketReach) |
Founded | 2006 |
Address | 4 Christoph-probst-weg, Hamburg, Hamburg 20251, DE |
Phone | +49 40 61136184 |
Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
Industry | Biotechnology, Pharmaceutical Manufacturing, Business Services General, Business Services, Science and Engineering, Drug Discovery, Developer Tools, Software, Medical, Health Care, Service Industry |
Web Rank | 15 Million |
Keywords | Dendritische Zelltherapie Bei Tieren, Proleukin (Human Rhil-2) |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Immunservice employee's phone or email?
The Immunservice annual revenue was $8 million in 2024.
Edith Huland is the Managing Director of Immunservice.
3 people are employed at Immunservice.
Immunservice is based in Hamburg, Hamburg.
The NAICS codes for Immunservice are [325, 32, 32541, 3254].
The SIC codes for Immunservice are [283, 28].